Substance / Medication

Ethynodiol diacetate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

52 trials linked to this intervention

52
Total Trials
6
Recruiting
16
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Experiences of pain communication in endometriosis: A meta-synthesis.
Robstad Nastasja, Paulsen Anita, Vistad Ingvild et al. · Acta Obstet Gynecol Scand · 2025
PMID: 39440568Meta-AnalysisFull text (PMC)
Efficacy of Gonadotropin Treatment for Induction of Spermatogenesis in Men With Pathologic Gonadotropin Deficiency: A Meta-Analysis.
Muir Christopher A, Zhang Ting, Jayadev Veena et al. · Clin Endocrinol (Oxf) · 2025
PMID: 39445789Meta-Analysis
Childhood adversity and risk of endometriosis, fibroids, and polycystic ovary syndrome: a systematic review.
Berndt Sara L, Ribeiro Leticia Watanabe, Rowlands Ingrid et al. · Fertil Steril · 2025
PMID: 39521113Meta-Analysis
Gonadotropin Therapy for Mini-Puberty Induction in Male Infants With Hypogonadotropic Hypogonadism.
Rhys-Evans Sophie, d'Aniello Francesco, Alexander Emma C et al. · J Clin Endocrinol Metab · 2025
PMID: 39673783Meta-AnalysisFull text (PMC)
Novel reversed-phase HPLC method for simultaneous determination of ethynodiol diacetate (EDA)/ethinyl estradiol (EE) in pharmaceutical dosage form.
Chinta Srinivasa Reddy, Ponnam Vijetha, Katari Naresh Kumar et al. · Biomed Chromatogr · 2021
PMID: 33368394Observational
Biocatalytic modifications of ethynodiol diacetate by fungi, anti-proliferative activity, and acetylcholineterase inhibitory of its transformed products.
Nurfazilah Wan Yusop Sharifah, Imran Syahrul, Ilham Adenan Mohd et al. · Steroids · 2021
PMID: 33831403Other
Biotransformation of oral contraceptive ethynodiol diacetate with microbial and plant cell cultures.
Zafar Salman, Yousuf Sammer, Kayani Hammad A et al. · Chem Cent J · 2012
PMID: 23021311OtherFull text (PMC)
Protective role of nordihydroguaiaretic acid (NDGA) against the genotoxic damage induced by ethynodiol diacetate in human lymphocytes in vitro.
Siddique Yasir Hasan, Ara Gulshan, Beg Tanveer et al. · J Environ Biol · 2007
PMID: 17915765Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Etynodiol diacetate (substance)
SNOMED CT
126105006
UMLS CUI
C0015117

Clinical Data

This intervention maps to 8 entities in the Ltrl knowledge graph.

2
Conditions
3
Biomarkers
2
Specialists
0
Symptoms
52
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.